2022 Nevada Revised Statutes
Chapter 639 - Pharmacists and Pharmacy
NRS 639.28077 - Self-administered hormonal contraceptive: Establishment of protocol for dispensing; regulations. [Effective January 1, 2022.]

1. The Board shall adopt regulations establishing a protocol for dispensing a self-administered hormonal contraceptive, as authorized by NRS 639.28078. Those regulations must include, without limitation:

(a) Requirements governing the information that must be included in a record concerning the dispensing of the self-administered hormonal contraceptive in addition to the information required by NRS 639.28078; and

(b) The amount of time that such a record must be maintained by the dispensing pharmacist or his or her employer.

2. The Board shall adopt regulations that prescribe:

(a) A risk assessment questionnaire that must be provided to a patient who requests a self-administered hormonal contraceptive pursuant to NRS 639.28078.

(b) The information that must be provided in writing to a patient to whom a self-administered hormonal contraceptive is dispensed pursuant to NRS 639.28078, which may include, without limitation, information concerning:

(1) The importance of obtaining recommended tests and screening from the patient’s attending provider or another qualified provider of health care who specializes in women’s health;

(2) The effectiveness of long-acting, reversible contraceptives as an alternative to self-administered hormonal contraceptives;

(3) When to seek emergency medical services as a result of administering a self-administered hormonal contraceptive; and

(4) The risk of contracting a sexually transmitted infection and ways to reduce that risk.

3. As used in this section:

(a) "Attending provider" means a provider of health care who provides or has provided care to the patient.

(b) "Provider of health care" has the meaning ascribed to it in NRS 629.031.

(Added to NRS by 2021, 3268, effective January 1, 2022)